 A chart review of U.S. healthcare providers found that calcipatrine 0.005% per beta-methasone depropionate 0.064% calc-BD, foam is a well-tolerated and effective topical therapy for psoriasis, with improvements in disease severity and associated itch reported in real clinical practice. This article was authored by Jashin J. Wu, Karen Avaverka, Meenie Lu, and others.